David A. Weil*, Zoltan Timar and Michael Zumwalt. Agilent Technologies. Schaumburg, IL/ Boulder, CO. Impurity Profiling 2008

Similar documents
Application Note. David A. Weil Zoltan Timar Michael Zumwalt Edgar Naegele. Abstract

Making Sense of Differences in LCMS Data: Integrated Tools

MassHunter TOF/QTOF Users Meeting

Agilent TOF Screening & Impurity Profiling Julie Cichelli, PhD LC/MS Small Molecule Workshop Dec 6, 2012

Application Note. Edgar Naegele. Abstract

An Effective Workflow for Impurity Analysis Incorporating High Quality HRAM LCMS & MSMS with Intelligent Automated Data Mining

Computer-assisted analysis of complex natural product extracts

QTOF Small Molecule Applications Update. April 10 th, David A. Weil. Application Scientist, Schaumburg, IL

Application Note. Edgar Naegele. Abstract

Overview. Introduction. André Schreiber AB SCIEX Concord, Ontario (Canada)

Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS

LC/MS/MS qua ntitation of β-estradiol 17-acetate using an Agilent 6460 Triple Quadrupole LC/MS working in ESI negative ion mode

TOF/QTOF Users Meeting. Jim Lau, Agilent Technologies.

Identification and Characterization of an Isolated Impurity Fraction: Analysis of an Unknown Degradant Found in Quetiapine Fumarate

A Workflow Approach for the Identification and Structural Elucidation of Impurities of Quetiapine Hemifumarate Drug Substance

Analytical Technologies and Compound Identification. Daniel L. Norwood, MSPH, PhD SCĪO Analytical Consulting, LLC.

WADA Technical Document TD2003IDCR

Application Note. Authors. Abstract. Introduction. Environmental

Analysis of Extractable and Leachable (E&L) Compounds Using a Low-Energy EI-Capable High Resolution Accurate Mass GC/Q-TOF

Pharmaceutical Impurity Identification and Profiling Using Agilent Q-TOF LC/MS Combined with Advanced MassHunter Data Processing Software

Confirmation of In Vitro Nefazodone Metabolites using the Superior Fragmentation of the QTRAP 5500 LC/MS/MS System

Agilent Technologies LCMS Portfolio

Screening of Pharmaceuticals and Personal Care Products in Effluents and Surface Waters with LCMS Q-TOF

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

Die Nadel im Heuhaufen

Analysis of Biomarkers in Crude Oil Using the Agilent 7200 GC/Q-TOF

Bioanalytical Chem: 4590: LC-MSMS of analgesics LC-MS Experiment Liquid Chromatography Mass Spectrometry (LC/MS)

Construction and Use of API Single- Quadrupole MS Spectral Libraries.

Accelerated Impurity Profiling Workflow for Bulk Drugs and Formulations using an Accurate Mass Workhorse

Agilent All Ions MS/MS

At-a-Glance. Verapamil C 27 H 38 N 2 O 4 M+H + =

All Ions MS/MS: Targeted Screening and Quantitation Using Agilent TOF and Q-TOF LC/MS Systems

Rapid Screening and Confirmation of Melamine Residues in Milk and Its Products by Liquid Chromatography Tandem Mass Spectrometry

Mass Spectrometry. Hyphenated Techniques GC-MS LC-MS and MS-MS

Identifying Disinfection Byproducts in Treated Water

MassHunter Software Overview

A Q-TOF Generated, Metabolomics- Specifi c LC/MS/MS Library Facilitates Identifi cation of Metabolites in Malaria Infected Erythrocytes

LC-MS Based Metabolomics

MS Interpretation I. Identification of the Molecular Ion

Multiple Fragmentation Methods for Small Molecule Characterization on a Dual Pressure Linear Ion Trap Orbitrap Hybrid Mass Spectrometer

Analysis of Polar Metabolites using Mass Spectrometry

TargetScreener. Innovation with Integrity. A Comprehensive Screening Solution for Forensic Toxicology UHR-TOF MS

Quantitative Analysis of Water-Soluble B-Vitamins in Cereal Using Rapid Resolution LC/MS/MS. Application. Authors. Abstract.

Separation of Enantiomers of Amphetamine-Related Drugs and Their Structural Isomers

Metabolomics Batch Data Analysis Workflow to Characterize Differential Metabolites in Bacteria

Accurate Mass Analysis of Hydraulic Fracturing Waters

Accurate Mass Analysis of Hydraulic Fracturing Waters: Identification of Polyethylene Glycol Surfactants by LC/Q-TOF-MS

Agilent 1290 Infinity Quaternary LC Stepwise Transfer to Methods with MS-Compatible Mobile Phases

Analyzing Compounds of Environmental Interest Using an LC/Q-TOF Part 1: Dyes and Pigments. Application. Introduction. Authors. Abstract.

ACD/AutoChrom Assisted Method Development for Challenging Separations. Vera Leshchinskaya February 7, 2018

Extend Your Metabolomics Insight!

Introducing the Agilent 7000A QQQ-MS for GC Sunil Kulkarni Product Specialist Agilent Technologies

AB SCIEX SelexION Technology Used to Improve Mass Spectral Library Searching Scores by Removal of Isobaric Interferences

Hypericin Analysis by LC/MS

Profiling of Diferulates (Plant Cell Wall Cross- Linkers) Using Ultrahigh-performance Liquid. Chromatography-Tandem Mass Spectrometry

Yun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION

A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies

De Novo Metabolite Chemical Structure Determination. Paul R. West Ph.D. Stemina Biomarker Discovery, Inc.

Welcome! Course 7: Concepts for LC-MS

Applying MRM Spectrum Mode and Library Searching for Enhanced Reporting Confidence in Routine Pesticide Residue Analysis

Accurate Mass Measurement for Intact Proteins using ESI-oa-TOF. Application Note. Donghui Yi and Christine Miller Agilent Technologies

Agilent Technologies at TIAFT 2013

Agilent MassHunter Profinder: Solving the Challenge of Isotopologue Extraction for Qualitative Flux Analysis

Thermo Scientific LTQ Orbitrap Velos Hybrid FT Mass Spectrometer

Developing a fast, generic method for rapid resolution LC with quadrupole MS detection. Application Note

Quantitation of High Resolution MS Data Using UNIFI: Acquiring and Processing Full Scan or Tof-MRM (Targeted HRMS) Datasets for Quantitative Assays

Tools for Structure Elucidation

LC walk-up system using the Agilent 1200 Series LC Method Development Solution and Agilent Easy Access software. Application Note

Determination of Chlorinated Acid Herbicides in Soil by LC/MS/MS Application Note

SUSPECT AND NON-TARGET SCREENING OF ORGANIC MICROPOLLUTANTS IN WASTEWATER THROUGH THE DEVELOPMENT OF A LC-HRMS BASED WORKFLOW

WADA Technical Document TD2015IDCR

The new Water Screening PCDL

Rapid method development to study plasma stability of diverse pharmaceutical compounds using Rapid Resolution LC and triple quadrupole MS

High-Throughput Protein Quantitation Using Multiple Reaction Monitoring

Plasma Metanephrines and 3-Methoxytyramine by LC/MS/MS Using Agilent SimpliQ WCX SPE, 1290 Infi nity LC, and 6460 Triple Quadrupole LC/MS

Identification and Quantitation of Pesticides in Chamomile and Ginger Extracts Using an Agilent 6460 Triple Quadrupole LC/MS system with Triggered MRM

PosterREPRINT COMPARISON OF PEAK PARKING VERSUS AUTOMATED FRACTION ANALYSIS OF A COMPLEX PROTEIN MIXTURE. Introduction

Determination of EU-Banned Disperse Dyes by LC/MSD TOF Application

Finnigan LCQ Advantage MAX

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

Analytical determination of testosterone in human serum using an Agilent Ultivo Triple Quadrupole LC/MS

Achieve confident synthesis control with the Thermo Scientific ISQ EC single quadrupole mass spectrometer

Acknowledgement: 4F-PBP (C14H18FNO) T: +386 (0) E: Vodovodna Ljubljana SLOVENIJA

ANALYTICAL REPORT 1. 4-Me-TMP (C15H21NO2) Remark other NPS detected: none. sample contains some impurities (benzeneacetic acid + others)

Workflow Using Hyphenated Mass Spectrometry Techniques

SEAMLESS INTEGRATION OF MASS DETECTION INTO THE UV CHROMATOGRAPHIC WORKFLOW

Agilent 6400 Series Triple Quadrupole Users Workshop. MH QQQ Users workshop 2/21/2014 1

ANALYTICAL REPORT 1 CUMYL-4CN-BINACA (C22H24N4O) 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide

Introduction to GC/MS

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Taking Full Advantage of UHPLC with Agilent 6460A Triple Quadrupole MS. Outline

Key Words Q Exactive, Accela, MetQuest, Mass Frontier, Drug Discovery

Quantitation of Cystine and Identification of Related Metabolites in White Blood Cells Using a High Resolution Accurate Mass LC/MS Approach

Cerno Application Note Extending the Limits of Mass Spectrometry

Determination of Pharmaceuticals in Water by SPE and LC/MS/MS in Both Positive and Negative Ion Modes

Impurities Sources, Detection and Measurement HPLC-MS Analyses. Dr Courtney Milner Chemical Analysis

Agilent LC & LC-MS Cannabis Testing

Accurate Mass for GC/MSD & LC/MSD

Application Note. Author. Abstract. Food Safety. Syed Salman Lateef Agilent Technologies, Inc. Bangalore, India

Lirui Qiao, 1 Rob Lewis, 2 Alex Hooper, 2 James Morphet, 2 Xiaojie Tan, 1 Kate Yu 3

Transcription:

Evaluation of the Importance of Accurate Mass, Mass Resolution and Dynamic Range for Impurity Profiling Applications with Multistage Mass Spectrometry David A. Weil*, Zoltan Timar and Michael Zumwalt Agilent Technologies Schaumburg, IL/ Boulder, C David_Weil@Agilent.com Page 1

Impurity Profiling.. Identification of Impurities in Active Pharmaceutical Ingredients (API) Arising from Manufacturing/Processing Differentiation from other Pharma Applications Chromatography, Quantitation, Identification Source of Impurities Residual Solvents, Intermediates, Catalysts, Processing Aids Techniques GC/MS, LC/UV, ICP/MS, LC/MS and LC/MS/MS Page 2

Traditional Method for Impurity Analysis Plant is Shutdown Product has Failed.. Why, When, Where, How Easy.. Just have Ph.D. Analytical Chemists Acquire Lots and Lot of GCMS and LCMS Data Dump data onto Coworkers Desk ID the Differences.. Manual, Biased Approach Look for Known Things First High/Low Major Differences Is the Change Real? Although Small a Needle in Hay Can Cause ne Pain Manually Compare LC/UV and MS Chromatograms from Control versus Contaminated Samples Page 3

API Degradation by Aging Pathways Hydrolysis, xidation, Dehydration, Ring Cleavage, Photolysis Challenge Identify low-level degradation products in the presence of the major API component Dream Solution All Components ID and Separated Chromatography Infinite Resolving Power and Ultra Fast Separation Mass Spec Infinite Scan Speed, Dynamic Range, Resolving Power with sub-ppm Mass Accuracy Reality: Coalition, ion suppression, limited dynamic range, accurate mass New Analog/Digital Technology Evaluate the Importance of Resolution, Accurate Mass, Dynamic Range with Automated Data Mining Tools for Impurity Profiling Page 4

Impurity Profiling Workflow: bjective: Detection - ID low-level Impurities in Active Pharmaceutical Ingredients. Targeted Analysis QQQ MRM Quantitation or Unknown ID Differential Analysis Impurity ID RRLC Q(TF) Control/Sample (3x) RT, MW, Formulas ID Compounds Mass Hunter MFE (databases) Mass Profiler ID RT, MW Unique Features ID Structures AutoMSMS EFG MS - MSMS Import Targeted MS/MS List RRLC MS/MS Page 5

Sensitivity versus Unknown Identification Ease of Use Scan speed Scan sensitivity Qualitative (identification, structural info) Sensitivity (specific detection) Quantitation (accuracy, precision) Better Single quad TF TF Q-TF (MS/MS w/ accurate mass) QQQ esp. dirty matrix, < 5 pg on-col. QQQ TF Q-TF Q-TF TF unknowns (acc. mass CID) Single quad (SIM) Single quad QQQ Single quad Single quad QQQ (MS/MS) TF (accurate mass EICs) TF Q-TF QQQ QQQ Single quad (CID) Q-TF * Q-TF * Page 6

Agilent LC/MS/MS Solution 1200 RRLC 6520 QTF Accurate Mass time-of-flight analyzer quadrupole collision cell Q-TF Analyzer Ion ptics Page 7

New Ultra High Speed Acquisition Intelligence at the Molecular Level 4 GHz (8 bit) Analog-Digital-Converter ADC Adapted from Agilent High Speed scilloscope Systems Ultra High Speed FPGA Processors and Memory 4Ghz peak detection 4Ghz gain scaling Up to 20,000 m/z depth Dual Input / Dual Gain High Bandwidth Input Amplifier for Extended Dynamic Range Picture of 4GHz board Goes here FPGAs Dual Input Amplifier 4 GHz ADC Page 8

Enhancements in Time-of-Flight and QTF New Acquisition Technology Increasing Resolving Power H Butyl paraben [M+H] + 195.10157 Methyl 5-acetylsalicylate [M+H] + 195.06519 H 8 bit 14 GHz Analog Digital Converter Transient Peak Apex Picking + 0.8 ppm 195.088679 195.100392 195.101392-0.9 ppm 0.036 Da 14,000 6,100 8,000 Resolving Power (FWHM) 195.065349 195.066356 FIA, 2 scans/sec (6713 transients/scan) 2 IRM averaged over five scans 195 195.02 195.04 195.06 195.08 195.1 195.12 195.14 195.16 195.18 195.2 Counts vs. Mass-to-Charge (m/z) Page 9

Enhanced Resolving Power Improved Mass Accuracy for Isobars Previous 1 GHz Sampling MAS 2.9 ppm (MAS) at high level, poor accuracy when BP abundance increases 128:1 dilution BP (unresolved, not detected at low levels) +1.3 ppm 1:1 MAS -0.2 ppm 128:1 dilution New 4 GHz Sampling -0.8 ppm 1:1 dilution BP 9.5 9.25 9 8.75 8.5 8.25 8 7.75 7.5 7.25 7 6.75 6.5 6.25 6 5.75 5.5 5.25 5 4.75 4.5 4.25 4 3.75 3.5 3.25 3 2.75 2.5 2.25 2 1.75 1.5 1.25 1 0.75 0.5 0.25 0 + Scan (# 3-7, 5 scans) MAS_BP_1_128.d Zoom view 128:1 dilution -1.4 ppm BP 195.02 195.04 195.06 195.08 195.1 195.12 195.14 195.16 195.18 195.2 195.22 Counts (%) vs. Mass-to-Charge (m/ z) 0 195 195.02195.04195.06195.08 195.1 195.12195.14195.16195.18 195.2 195.22 Counts vs. Mass-to-Charge (m/z) H Methyl 5-acetyl-salicylate (MAS) [M+H] + 195.065185 H 195.02 195.04 195.06 195.08 195.1 195.12 195.14 195.16 195.18 195.2 195.22 Counts (%) vs. Mass-to-Charge (m/z) Butyl paraben (BP) [M+H] + 195.101571 Page 10

Extended Dynamic Range Mode Hardware (32 staggered ADCs) Real Time Signal Processing and Summing Memory SIGNAL Frontend_A Frontend_B Dual Gain Front End Amplifilers Agilent TALN ADC 4GSPS 8-BIT CLCK 4GSPS BUS 2GSPS BUS FPGA Master FPGA Slave PULSE CNTRL BUS DATA T INSTRUMENT CNTRLLER Page 11

Extended Dynamic Range Mode 12X Time Data from low gain channel Time signal Time Final spectrum gain transition Time Data from high gain channel Page 12

Extended Dynamic Range Up To 5 Decades f In-Spectrum Dynamic Range Max Abd 3.6x10 7 x10 6 9 8.8 8.6 8.4 8.2 8 7.8 7.6 7.4 7.2 7 6.8 6.6 6.4 6.2 6 5.8 5.6 5.4 5.2 5 4.8 4.6 4.4 4.2 4 3.8 3.6 3.4 3.2 3 2.8 2.6 2.4 2.2 2 1.8 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 + Scan (# 31-35, 5 scans) niacinamide_erythromycin.d * 123.055394 9x10 6 cts Niacinamide, 10 ng/µl [M+H] + = 123.055289 m/z Error = +0.8 ppm In-Scan Dynamic Range This Example 9x10 6 / 250 = 3.6 10 4 Maximum 3.6x10 7 / 250 = 1.4x 10 5 250 cts 207.007866 329.056151 425.138434 659.287715 759.355249 922.009798 1221.991581 1521.971969 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250 1300 1350 1400 1450 1500 1550 1600 1650 1700 Counts vs. Mass-to-Charge (m/ z) x10 2 2.5 2.4 2.3 2.2 2.1 2 1.9 1.8 1.7 1.6 1.5 1.4 1.3 1.2 1.1 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 + Scan (# 31-35, 5 scans) niacinamide_erythromycin.d 734.468956 Erythromycin, 500 fg/µl [M+H] + = 734.468518 m/z Error = +0.6 ppm 735.416113 736.387755 734 734.5 735 735.5 736 736.5 737 737.5 738 738.5 739 739.5 740 740.5 Counts vs. Mass-to-Charge (m/ z) Page 13

Mass Accuracy Function of Acquisition State High Res -0.1ppm -0.53ppm 0.94 ppm -0.31ppm -0.31ppm -1,01ppm 1.74 ppm -0.03ppm Extended DR Page 14

Resolution Comparison High Resolution Mode 15K Resolution 0.98 ppm Extended Dynamic Range 8.5K Resolution 0.99 ppm 12K Resolution 0.09 ppm 8.5K Resolution -0.18 ppm Page 15

Application of Enhanced Resolving Power C 9 H 10 N Product from Albuterol from C 10 H 13 N [C 9 H 11 N] + [C 10 H 14 N] + [C 9 H 11 N] + Page 16

Automated Data Analysis Show me the Data Find Compounds from Background MFE Algorithm Differential Analysis Mass Profiler Software Identification: Molecular Formula Generation, Databases Automation: MetID for Impurity Profiling Page 17

Molecular Feature Extraction (MFE) Automated Data Reduction Software Finds Features in TF/QTF Data 3D 3D Plot Plot Before No Coeluting Features Background riginal TIC Processed TIC Data Reduced sum intensities of isotopes, adducts, clusters and multiply charges ions together. Page 18

Molecular Feature Extraction (MFE) Generate Empirical Formulas Molecular Formula Generation and Database Search Page 19

Prednisolone: C 21 H 28 5 360.193674 H CH 3 CHH 3 CH 3 2 year old Suspension Page 20

Sequential Neutral Water Losses Detected x10 5 + ECC Scan Prednisolone0002.d 1.2 1.1 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 13.421 23081.8 0.1 0 8.5 9 9.5 10 10.5 11 11.5 12 12.5 13 13.5 14 Counts vs. Acquisition Time (min) Page 21

12 Potential Degradation Products in Prenisolone CH 2 Loss -H 2, -H 2, -C 2 H 2, +H 2, +CH 4 +H 2 -, Page 22

Prednisolone 342 CH 3 H 358 CH 3 CHH 3 H CH 3 344 CHH H 3 CH 3 CH 3 362 H CH H 3 CH 3 CH 3 344 CH 3 H 374 H CH 3 CH H 3 H CH 3 CH 3 Page 23

Is 6-methyl Prednisolone Present? [M+H]+ 375 Page 24

C 16 H 19 N 3 S 5 Degradation Products of Amoxicillin and AmoxClavin MW 365.10454 NH 2 Source Tablet 875mg New Tablet 500mg 09/07 Sample Preparation H NH N S H CH 3 CH 3 Tablets Dissolved in 40mL Methanol Water with 0.1% Formic Acid Syndicated 20 minutes Spin 5 minutes 14000 RPM Dilute 100 and 1000 fold with water Page 25

Experimental Conditions Chromatography Agilent 1200 RRLC Ecilpse Plus C18 2.1x100mm 1.8µm heated to 50 o C Mobile Phase: Water/Methanol 0.1% FA Water/Methanol 5mM NH4Ac Multiple Gradients Tested 0 to 95% in 16 Minutes 0 to 95% in 13 Minutes Flow Rate: 400-500 µl/min Mass Spectrometry Agilent 6520 QTF Positive ion ESI Mass Range m/z 100-1000 Acquisition Rate: 2 spectra/s Drying Gas: 250 o C Internal Reference Mass m/z 121 and 922 Fragmenter: 165C Enhanced and High Resolution Modes Page 26

Buffer in Mobile Phase 10X Enhancement with NH 4 Acetate 0.1% Formic Acid 5mM NH 4 Acetate Page 27

Effect of Gradient 14 Separated Degradation Products 0-95% in 13 minutes 10 Separated Degradation Products 0-25% in 13 minutes Page 28

Degradation Pathway of Amoxicillin (previous TF/Trap work) H H H H CH H CH NH NH 2 N CH 3 H 2 NH CH NH 3 H 2 NH NH S CH 3 S CH 3 H H H H H H 1 2 3 NH H NH S H CH CH 3 CH 3 H H N H 2 H H CH NH H N CH 3 NH S CH 3 H H H 5 4 H N N H HN H S CH CH 3 CH 3 1 Amoxicillin 2 Amoxicillin penicilloic acid 3 Amoxicillin penilloic acid 4 Diketopiperazine amoxicillin 5 4-Hydroxyphenylglyl amoxicillin E. Naegele, R. Moritt, J. Am. Soc. Mass Spectrom. 2005, 16, 1670-1676 Page 29

Accurate Mass: High Resolution Mode RT [min] Compound name Formula Calculated mass Measured Mass Mass accuracy accuracy Mass [mda] [ppm] 3.71 amoxicillin penicilloic acid 2 C 16 H 22 N 3 6 S 384.1229 384.12274-0.93-0.36 3.84 amoxicillin 1 C 16 H 20 N 3 5 S 366.1124 366.11222 1.09-0.4 4.57 amoxicillin penilloic acid I and II 3 C 15 H 22 N 3 4 S 340.1331 340.13352-2.84-0.96 5.954 Amoxicillin Acid C 17 H 23 N 3 S 6 398.13803 398.13826-0.58-0.23 6.269 diketopiperazine amoxicillin 5 C 16 H 20 N 3 5 S 366.1124 366.11286-2.85-1.04 Page 30

Structural Information from MS/MS C 16 H 19 N 3 S 5 H H NH 2 NH H H N S H CH CH 3 CH 3 H N N H HN H S CH CH 3 CH 3 H C 6 H 10 N 2 S 3.53 ppm Error Page 31

Differential Analysis Using Mass Profiler Page 32

Impurity Analysis: Mass Profiling Software Processed Processed TIC Processed TIC Group TIC A (Impure) Processed Processed TIC Processed TIC Group B TIC (Control) Aligns Data RT, Mass, Abundance What s Changed? Mass/RT >2 Fold Change What s All Unique!! Data RT/Mass Impurity Control Page 33

S/N 5:1, RI > 0.01%, Mass 200-600, RT 1-11 Minutes 835 Features Page 34

36 Features after Filtering Isotope Pattern, Background Subtraction, # Ions Page 35

Detected 17 Degradation Products Page 36

Composition and Database Searching Page 37

MetID Software For Impurity Profiling Page 38

verview MetID 1. Parent Compound: MW, Formula and Structure 2. Transformations: List Proposed Degradation Products 3. Identification Criteria: Vary Importance of Tests 4. Find Compounds by MFE: Molecular Feature Extraction 5. Find Compounds by AutoMSMS: For MSMS data 6. Sample Comparison: Mass Profiler What is Different 7. Isotope Pattern Filtering: Best for Halogenated Species 8. Mass Defect Filtering: From Proposed Compounds 9. EIC Generation: Confirms Presence of Compounds Page 39

Page 40

Method Input Parent Compound Propose Degradation Products Page 41

Proposed Degradation Products Qualified by Mass Defect and Isotope Pattern Let s Determine Composition of MW 411 Page 42

Accurate Mass Generates Composition Acid Hydrolysis (H 2 +C 2 H-H) Accurate Mass of Fragments Ions Page 43

verlay MSMS Spectrum Parent/Product Page 44

MSMS of MW 380 Compound Page 45

3D of MSMS Spectra Fragmentation Pattern Page 46

Summary: 1. New 4GHz A/D Electronics, Resolution > 10,000: m/z > 100, Which Enables Resolving Trace Level Degradation Products from Chemical Background 2. Automated Data Analysis: Molecular Feature Extraction 3. Differential Analysis: MassProfiler 4. Identification: Personal Metlin Database 5. Impurity Profiling: MetID Software with MS/MS Data Page 47

Acknowledgements Edgar Naegele Agilent Technologies, Germany Lehmann Horst Agilent Technologies, Germany Patrick Perkins Agilent Technologies, Santa Clara CA Mike Woodman Agilent Technologies, Schaumburg, IL Dawn Kasper, RDH Buffalo Grove, IL Thank you.. Kentucky Fried Chicken Boulder, C.. For being open at 10:50pm. Thank you.. For your Attention.. Page 48

References: J. Roy, AAPS PharmSciTech, 2002, 3,(2) L. Zhou, B. Mao, R. Reamer, T. Novak, Z. Ge, J Pharm. Biomed. Analysis, 44(2007) 421-429 S. Erram; C. Fanska, M. Asif; J Pharm. Biomed. Analysis; 40(2006)864-874 Y. Wu; Biomed Chromatography; 14(2000) 384-396 Page 49

Albuterol Sulfate/Levosalbutamol C 13 H 21 N 3 MW 239.15214 Sources H CH 3 CH 3 NH CH 3 Syrup 2MG/ML 10/26/99 Aerosol 90ug/dose New Suspension 0.65mg/3mL New Add reference article H H Page 50

Loratadine C 22 H 23 N 2 2 Cl MW 383.15257 Source Cl N Syrup 10mg/mL 05/02 Claritan D 07/02 N CH 3 Page 51

Naproxen C 14 H 14 3 MW 230.094294 Source Tablet 500mg 08/97 H CH 3 CH 3 Tablet 220mg New Page 52

Diphenoxylate Diphenoxylate C 30 H 32 N 2 2 MW 452.246378 H 3 C Atropine N C 17 H 23 N 3 ME 289.16 Source Tablet 5/1994 CH 3 N N H Page 53

Hyosophen-Donnatal Phenobarbital C 12 H 12 N 2 3 MW 232.084794 Atropine C 17 H 23 N 3 MW 289.16 Scopolamine C 17 H 21 N 4 MW 303.147058 Tablets 90mg 1/97 H H 3 C CH 3 N NH NH Page 54

Atarax Atarax H C 21 H 27 N 2 2 Cl MW Source Tablet 10mg 7/2002 N N Cl Page 55